0001594864-14-000001.txt : 20140508 0001594864-14-000001.hdr.sgml : 20140508 20140508142759 ACCESSION NUMBER: 0001594864-14-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140508 DATE AS OF CHANGE: 20140508 EFFECTIVENESS DATE: 20140508 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Juno Therapeutics, Inc. CENTRAL INDEX KEY: 0001594864 IRS NUMBER: 463656275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-217030 FILM NUMBER: 14824336 BUSINESS ADDRESS: STREET 1: 307 WESTLAKE AVENUE NORTH, SUITE 300 CITY: SEATTLE STATE: WA ZIP: 98109 BUSINESS PHONE: 2066960703 MAIL ADDRESS: STREET 1: 307 WESTLAKE AVENUE NORTH, SUITE 300 CITY: SEATTLE STATE: WA ZIP: 98109 D 1 primary_doc.xml X0707 D LIVE 0001594864 Juno Therapeutics, Inc. 307 WESTLAKE AVENUE NORTH, SUITE 300 SEATTLE WA WASHINGTON 98109 2066960703 DELAWARE FC Therapeutics, Inc. None Corporation true 2013 Hans Bishop 307 Westlake Avenue North Suite 300 Seattle WA WASHINGTON 98109 Executive Officer Director Promoter Robert Nelsen 307 Westlake Avenue North, Suite 300 Seattle WA WASHINGTON 98109 Director Promoter Rick Klausner 307 Westlake Avenue North, Suite 300 Seattle WA WASHINGTON 98109 Director Promoter Marc Tessier-Lavigne 307 Westlake Avenue North, Suite 300 Seattle WA WASHINGTON 98109 Director Howard Pien 307 Westlake Avenue North, Suite 300 Seattle WA WASHINGTON 98109 Director Anthony Evnin 307 Westlake Avenue North, Suite 300 Seattle WA WASHINGTON 98109 Director Biotechnology Decline to Disclose 06b false 2014-04-24 false true true false 0 97000000 28423971 68576029 false 34 0 0 0 false Juno Therapeutics, Inc. /s/Hans Bishop Hans Bishop Chief Executive Officer 2014-05-08